What stands out in progress against breast cancer over the last five years, and where do we need to do more?
Findings from the TAILORx clinical trial will help personalize treatment decisions for many patients with early stage breast cancer.
A look back on three years of blogging about cancer research from the patient perspective, and a few thoughts looking ahead.
Prominent breast cancer researchers spoke about innovative approaches in metastatic breast cancer research at NBCC’s 2016 Advocate Summit.
A major new report details action needed to accelerate progress against metastatic breast cancer so that it can be treated as a manageable condition with good quality of life.
After thirty years of Breast Cancer Awareness Month, actual progress against the disease has not met expectations, with over 40,000 deaths from the disease annually in the United States.
Here are a few of the recent stories about cancer research that seemed to have the greatest potential impact, as least from my perspective, and that I know I’ll want to follow as they develop further.
In the last twenty years, there have been some advances in breast cancer treatment and many more women are screened each year, but these advances have not brought about transformational change in the way breast cancer is treated or in mortality from the disease.